BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 287 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,831,000 | -4.9% | 31,959 | -8.3% | 0.06% | 0.0% |
| Q2 2022 | $5,080,000 | +22.0% | 34,866 | -0.7% | 0.06% | +47.7% |
| Q1 2022 | $4,165,000 | -39.6% | 35,127 | -29.8% | 0.04% | -37.1% |
| Q4 2021 | $6,892,000 | -32.7% | 50,011 | -32.2% | 0.07% | -31.4% |
| Q3 2021 | $10,248,000 | +41.1% | 73,777 | -1.4% | 0.10% | +41.7% |
| Q2 2021 | $7,265,000 | +36.2% | 74,840 | -4.1% | 0.07% | +28.6% |
| Q1 2021 | $5,336,000 | +43.2% | 78,063 | +79.6% | 0.06% | +33.3% |
| Q4 2020 | $3,725,000 | +29.1% | 43,460 | -2.1% | 0.04% | +7.7% |
| Q3 2020 | $2,885,000 | -24.1% | 44,372 | -14.6% | 0.04% | -27.8% |
| Q2 2020 | $3,799,000 | +145.9% | 51,964 | +14.5% | 0.05% | +107.7% |
| Q1 2020 | $1,545,000 | -40.1% | 45,388 | -4.2% | 0.03% | -21.2% |
| Q4 2019 | $2,580,000 | – | 47,384 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |